title: Thrombin activatable fibrinolysis inhibitor activity, thrombin-antithrombin complex and D-dimer levels in preterm neonates with early respiratory distress syndrome.
abstract: Intraalveolar fibrin deposition found in neonates with respiratory distress syndrome (RDS) is explained by the activation of the coagulation system and inefficient fibrinolysis. However, thrombin activatable fibrinolysis inhibitor activity (TAFIa), an inhibitor of fibrinolysis, and the ratio of D-dimer to thrombin-antithrombin complex (D-dimer/TAT), an index of fibrinolytic activity, have not been reported previously in neonatal RDS. Aim of this study is to evaluate the influence of plasma TAFIa levels on the fibrinolytic state in neonatal RDS. The RDS group (Group 1) consisted of 29 neonates, and 18 neonates served as the control group (Group 2). Plasma TAFIa levels and D-dimer/TAT ratios were evaluated in all neonates in the first 6 hr of life. Neonates in the RDS group were further divided into two subgroups; Group 1a consisted of 12 neonates with evidence of mild asphyxia (Apgar score at 5 min <7 and cord pH <7.26), and Group 1b consisted of 17 nonasphyxiated neonates. No significant difference was found in TAFIa levels and D-dimer/TAT ratios between Groups 1 and 2 [214% (56.2-361%) and 124.3 (4.4-3,921) in Group 1 and 201% (60.3-381%) and 147 (5.9-1,426) in Group 2]. There were negative correlations between cord pH and TAFIa levels in both groups. Increased TAFIa levels and decreased D-dimer/TAT ratios and platelet counts were detected in mildly asphyxiated neonates when compared with nonasphyxiated ones. TAFIa is not responsible for the hypofibrinolytic state reported in RDS. However, asphyxia influences TAFIa levels and increased TAFIa levels depress fibrinolysis.
authors.affiliation: Neonatology Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. tugbagursoy@gmail.com
authors.forename: Tugba
authors.initials: T
authors.lastname: Gursoy
authors.forename: Gulsevin
authors.initials: G
authors.lastname: Tekinalp
authors.forename: Murat
authors.initials: M
authors.lastname: Yurdakok
authors.forename: Osman
authors.initials: O
authors.lastname: Ozcebe
authors.forename: Ayse
authors.initials: A
authors.lastname: Korkmaz
authors.forename: Aytemiz
authors.initials: A
authors.lastname: Gurgey
mesh_terms: D000991:Antithrombins / Q000378:metabolism*; D025901:Carboxypeptidase B2 / Q000378:metabolism*; D019281:Dimerization; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D008297:Male; D010976:Platelet Count; D012127:Respiratory Distress Syndrome, Newborn / Q000378:metabolism*; D013917:Thrombin / Q000378:metabolism*; D013997:Time Factors
chemical_list: D000991:Antithrombins; D025901:Carboxypeptidase B2; D013917:Thrombin